Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC for Adrenocortical Carcinoma
NCT01833832Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2013
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in adrenocortical carcinoma (ACC), sponsored by National Cancer Institute. Started Apr 2013; status: completed.
02
Drugs
cisplatin
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT01833832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833832.